与年龄相关的黄斑变性和大脑粉样蛋白血管病变具有类似的病理,由胆固醇-APOE-粉样蛋白-β补充剂介导的炎症引起
Whitney Stuard Sambhariya1, Catherine Bowes Rickman2, Patricia A D'Amore3
1Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore Maryland.
Progress in retinal and eye research
|February 18, 2026
概括
与年龄相关的黄斑变性 (AMD) 和大脑粉样血管病变 (CAA) 具有共同的病理特征,包括粉样β积累. 这篇评论探讨了它们的相似和独特的病理生物学,为这些神经退行性疾病提供了新的见解.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 和阿尔茨海默病 (AD) 是普遍存在的神经退行性疾病.
- AMD导致视力丧失,而AD导致认知能力下降.
- 细胞外粉样β积累是一种共享的组织病理学标志.
- 大脑粉样蛋白血管病变 (CAA) 涉及大脑血管中的粉样蛋白-β沉积.
研究的目的:
- 为了比较AMD和CAA的病理生物学.
- 在它们的基础机制中识别共同点和差异.
- 为这些疾病的病理生物学提供新的视角.
主要方法:
- 关于AMD和CAA病理生物学现有文献的综述.
- 病理特征的比较分析.病理特征的比较分析.
- 讨论共享和独特的分子途径.
主要成果:
- AMD 和 CAA 具有共同的病理特征,特别是粉样β 积累.
- 病理生物学上的相似之处包括胆固醇代谢,阿波利波蛋白E,粉样蛋白-β和补充介导炎症.
- 还确定了它们病理生物学中的关键差异.
结论:
- 在它们的病理生物学上,AMD和CAA表现出显著的重叠.
- 了解这些相似之处和差异可以为神经退行症提供新的见解.
- 对共享途径的进一步研究可能会揭示治疗点.
相关概念视频
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Coronary Artery Disease II: Pathophysiology
646
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646
Atherosclerosis I: Introduction
1.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils
6.5K
6.5K
Peripheral Artery Disease I: Introduction
426
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
426


